OpGen Presents Data at ASM Microbe 2018 Demonstrating High Accuracy of Acuitas® for Predicting Antibiotic Resistance in Urine Specimens
OpGen, Inc. (OPGN)
Last opgen, inc. earnings: 11/6 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.opgen.com
Company Research
Source: GlobeNewswire
90% accuracy data presented for rapid antibiotic resistance prediction using Acuitas AMR Gene Panel and Acuitas Lighthouse on urine clinical specimens Prospective clinical trial in Colombia demonstrates 57% improvement in survival and reductions in antibiotic usage when OpGen rapid diagnostic test used GAITHERSBERG, Md., June 12, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today announced the presentation of data from the first phase of its Acuitas® urine clinical verification study demonstrating high accuracy in predicting antibiotic resistance in urine specimens. In the study, remnant urine specimens were provided by Intermountain Healthcare and Beth Israel Deaconess Medical Center and were tested with the Acuitas AMR Gene Panel u5.47 (Research Use Only ‘RUO’) to detect 5 pathogens and 47 resistance genes common to urinary tract infections. From the resulting genetic data, the Acuitas Lighthouse® Software (RUO) then predicted antibiotic resistance with greater than 9
Show less
Read more
Impact Snapshot
Event Time:
OPGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OPGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OPGN alerts
High impacting OpGen, Inc. news events
Weekly update
A roundup of the hottest topics
OPGN
News
- OpGen Receives Nasdaq Notice Regarding Delayed Form 10-K [Yahoo! Finance]Yahoo! Finance
- OpGen Receives Nasdaq Notice Regarding Delayed Form 10-KGlobeNewswire
- OpGen, Inc. (NASDAQ: OPGN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- OpGen, Inc. (NASDAQ: OPGN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- OpGen, Inc. (NASDAQ: OPGN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
OPGN
Earnings
- 11/14/23 - Miss
OPGN
Sec Filings
- 4/26/24 - Form DEF
- 4/25/24 - Form SC
- 4/25/24 - Form 4
- OPGN's page on the SEC website